John Androsavich

Company: Pfizer

Job title: Head of Global Ribonucleic Acid & Emerging Science Lead

Seminars:

Panel Discussion – LNP Beyond Vaccination – What’s Next?
Moderated by: Russell Johnson 9:00 am

The COVID-19 LNP-mRNA vaccine shone the spotlight on LNP potential as a clinically effective delivery mechanism and drove huge re-investment across biopharma and manufacturing facilities. However, their clinical utility doesn’t stop at vaccination, and now doors have opened for new applications. Hear experts outline the LNP landscape as it stands, and what’s next from gene…Read more

day: Conference Day One